Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: John Lacelle who wrote (714)	12/1/1998 11:36:00 AM
From: Cage Rattler	Read Replies (1) \| Respond to of 1255

John: I doubt this battered stock has a significant chance to recover. I plan a tax write-off and would not recommend CORX be purchased at this time. Good lord, and we are at all-time market highs -- what do you think will happen to CORX in a real bear market? Forget the "great drug, patents, and alleged results," that was attractive 6 months ago, not today. At this juncture buying CORX would be like investing in powerball tickets; sure there is a shot but the odds are very, very poor. There is something seriously wrong with/at CORX; management has been aware of what is going down, and they have been less than forthright with the stockholders. There has been a 90% loss of value on very high volume and that is not random nor day trading; what else needs to be said? Money into ENMD on a dip, for example, is a far better risk:reward purchase. If CORX rises above 1-dollar before the meeting I might revise my dismal prognosis -- but that seems unlikely. Ciao, Ted